Cortical Hyperostosis after Long-Lasting Prostaglandin E1 Treatment in a Newborn with Complex Congenital Heart Disease

J Pediatr. 2020 Nov:226:302-303. doi: 10.1016/j.jpeds.2020.07.067. Epub 2020 Jul 25.

Authors

Antonio Celona¹, Claudio Giardina¹, Salvatore Pappalardo¹, Aurelio Secinaro², Lilia Oreto³, Salvatore Agati³, Placido Romeo⁴

Affiliations

¹ Radiology Department, S. Vincenzo Hospital, Taormina - ASP Messina.
² Advanced Cardiovascular Imaging Unit, Department of Imaging, Bambino Gesù Children's Hospital, IRCCS, Rome.
³ Mediterranean Pediatric Cardiologic Centre (CCPM), S. Vincenzo Hospital, Taormina - Bambin Gesù Roma.
⁴ Radiology Department, S. Vincenzo Hospital, Taormina - ASP Messina, Italy.

PMID: 32721399
DOI: 10.1016/j.jpeds.2020.07.067

No abstract available

Publication types

Case Reports

MeSH terms

Alprostadil / administration & dosage
Alprostadil / adverse effects*
Female
Heart Defects, Congenital / drug therapy*
Humans
Hyperostosis / chemically induced*
Hyperostosis / diagnosis*
Infant, Newborn
Vasodilator Agents / administration & dosage
Vasodilator Agents / adverse effects*

Substances

Vasodilator Agents
Alprostadil